Allogene Therapeutics is a company that provides T cell, Cancer, Biotechnology and more. Allogene Therapeutics is headquartered in United States North America. Allogene Therapeutics was founded in 2017. and was founded by David Chang, Joshua Kazam. Allogene Therapeutics has a total of 297 patents and 2 literature
Option and Evaluation Partnership Terms and Agreements
Download
Innovation Matrix
visualizing technology portfolio of hot application areas and blank areas for Allogene Therapeutics
Time Range:
Overall
Overall
1 year
3 year
5 year
Application Domain L2
Application Domain L2
Application Domain L3
Application Domain L4
High-Tech Industry L1
High-Tech Industry L2
Tech Topic L2
Tech Topic L3
Timeline
Tech Topic L2
Tech Topic L2
Tech Topic L3
High-Tech Industry L1
High-Tech Industry L2
Application Domain L2
Application Domain L3
Application Domain L4
Download
Subsidiary Lists
Subsidiaries with patent applications for Allogene Therapeutics
Sign up to view the full data
Free Trial Now
Download
Top Related Companies
Sign up to view the full data
Free Trial Now
Allogene Therapeutics Frequently Asked Questions
What is Allogene Therapeutics's industry?
Allogene Therapeutics is in the industry of:Research and Development in the Physical, Engineering, and Life SciencesPharmaceutical and Medicine ManufacturingResearch and Development in the Social Sciences and HumanitiesProfessional Organizations Professional and Management Development Training
What technical fields has Allogene Therapeutics researched?
Allogene Therapeutics is a clinical stage immuno-oncology company. It is mainly engaged in the development and commercialization of genetically engineered...